Bill Hunter
Director/Board Member presso ADHERIUM LIMITED
Profilo
William L.
Hunter was the founder of Angiotech Pharmaceuticals, Inc. (founded in 1992) and Canary Medical, Inc. (founded in 2012), where he holds the titles of President & Chief Executive Officer.
Currently, Dr. Hunter is the Director at Michael Smith Foundation for Health Research and holds the position of Independent Non-Executive Director at Adherium (NZ) Ltd., Adherium Ltd., Soundbite Medical Solutions, Inc., Summatix Pty Ltd., Richardson Capital Ltd., Premier's Technology Council, and Bioscience Managers Pty Ltd.
In his former positions, Dr. Hunter served as President, Chief Executive Officer & Director at Correvio Pharma Corp.
(2007-2019), Chairman at Neuromed Pharmaceuticals Ltd., Director at AnorMED, Inc., Director at CombinatoRx, Inc. (2009-2010), Director at Aspreva Pharmaceuticals Corp.
(2006-2008), Non-Executive Director at Union MedTech Plc (2012-2014), Director at Active Pass Pharmaceuticals, Inc., Director at Zalicus, Inc. (2009-2012), Non-Executive Director at Rex Bionics Plc (2012-2017), and Independent Director at EPIRUS Biopharmaceuticals, Inc. (2009-2016).
Dr. Hunter completed his undergraduate degree at McGill University in 1985 and his graduate and doctorate degrees at the University of British Columbia in 1989 and 1992, respectively.
Posizioni attive di Bill Hunter
Società | Posizione | Inizio |
---|---|---|
ADHERIUM LIMITED | Director/Board Member | 17/12/2015 |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Director/Board Member | 17/12/2015 |
Soundbite Medical Solutions, Inc.
Soundbite Medical Solutions, Inc. Medical SpecialtiesHealth Technology SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada. | Director/Board Member | - |
Summatix Pty Ltd.
Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Director/Board Member | - |
Canary Medical, Inc.
Canary Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada. | Chief Executive Officer | 01/01/2012 |
Richardson Capital Ltd.
Richardson Capital Ltd. Investment ManagersFinance Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada. | Corporate Officer/Principal | 10/01/2011 |
Premier's Technology Council | Corporate Officer/Principal | - |
Michael Smith Foundation for Health Research
Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Director/Board Member | - |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Consultant / Advisor | - |
Precedenti posizioni note di Bill Hunter
Società | Posizione | Fine |
---|---|---|
░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Bill Hunter
McGill University | Undergraduate Degree |
University of British Columbia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
EPIRUS BIOPHARMACEUTICALS, INC. | Health Technology |
ADHERIUM LIMITED | Health Technology |
Aziende private | 18 |
---|---|
Angiotech Pharmaceuticals, Inc.
Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada. | Health Technology |
Correvio Pharma Corp.
Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases. | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Health Technology |
Union MedTech Plc
Union MedTech Plc Financial ConglomeratesFinance Union MedTech Plc is engaged in employing a buy and build strategy in the medical device arena. It is seeking to acquire and aggregate a number of proprietary medical device technologies in the areas, like orthopaedic and cardiac devices, as well as in novel areas such as bringing together complementary drug and device technologies. The company is focused on aggregating complementary technologies and adding significant value through clinical advancement, operational synergies and experienced management. The company was founded on November 13, 2007 and is headquartered in London, the United Kingdom. | Finance |
Neuromed Pharmaceuticals Ltd.
Neuromed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Neuromed Pharmaceuticals Ltd. develops chronic pain drugs. Its NMED-1077 product is an extended release formulation of hydromorphone in phase 3 clinical development. It conducts research for drugs to cure anxiety, epilepsy, hypertension, and cardiovascular diseases. The company was founded by Dr. Terrance P. Snutch in 1998 and is headquartered in Vancouver, BC. | Health Technology |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Health Technology |
Richardson Capital Ltd.
Richardson Capital Ltd. Investment ManagersFinance Richardson Capital Ltd. (Richardson Capital) is a private equity arm of Richardson Financial Group Ltd founded in 2003. The firm is headquartered in Winnipeg, Canada. | Finance |
Premier's Technology Council | Government |
Michael Smith Foundation for Health Research
Michael Smith Foundation for Health Research Investment Trusts/Mutual FundsMiscellaneous The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012. | Miscellaneous |
Adherium (NZ) Ltd.
Adherium (NZ) Ltd. Packaged SoftwareTechnology Services Adherium (NZ) Ltd. develops digital health technologies that address sub-optimal medication use in chronic disease. It offers Smartinhaler platform. The firm delivers original equipment manufacturer (OEM) products, software and services via development, regulatory, licensing, and supply and support agreements. The company was founded by Sutherland Garth Campbell in 2001 and is headquartered in Auckland, New Zealand. | Technology Services |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance BioScience Managers Pty Ltd (Bioscience Managers) is a private equity & venture capital firm founded in 2003 by Jeremy Curnock Cook. The firm is headquartered in Melbourne, Australia. | Finance |
Rex Bionics Plc
Rex Bionics Plc Medical SpecialtiesHealth Technology Rex Bionics Plc engages in the development and manufacture of hands-free robotic exoskeletons designed to enable a wheelchair user to stand and walk. The company was founded by Richard Little and Robert Irving on November 13, 2007 and is headquartered in Marlow, the United Kingdom. | Health Technology |
Soundbite Medical Solutions, Inc.
Soundbite Medical Solutions, Inc. Medical SpecialtiesHealth Technology SoundBite Medical Solutions Inc. offers medical devices. It develops and commercializes proprietary shockwave device and generator technology. The company was founded by Steve Arless, Martin Brouillette, Louis-Philippe Riel and Steven Dion and is headquartered in Montreal, Canada. | Health Technology |
Summatix Pty Ltd.
Summatix Pty Ltd. Internet Software/ServicesTechnology Services Summatix Pty Ltd. operates as a medical data monetization platform. The firm provides connectivity to its HIPAA compliant platform, software, APIs, and data management. The company is headquartered in Melbourne, Australia. | Technology Services |
Canary Medical, Inc.
Canary Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Canary Medical, Inc. develops medical devices to collect medical data. The company was founded by William L. Hunter and is headquartered in Vancouver, Canada. | Electronic Technology |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Bill Hunter